Follow
Edward Tobinick
Edward Tobinick
Founder, Institute of Neurological Recovery
Verified email at ucla.edu - Homepage
Title
Cited by
Cited by
Year
TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study
E Tobinick, H Gross, A Weinberger, H Cohen
Medscape General Medicine 8 (2), 25, 2006
3792006
Cytokine antagonists for the treatment of localized disorders
EL Tobinick
US Patent 6,419,944, 2002
3242002
Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration
EL Tobinick, H Gross
Journal of neuroinflammation 5, 1-10, 2008
3192008
Cytokine antagonists for the treatment of localized disorders
EL Tobinick, E Sutton, TK Page, L Channavajjala
US Patent 6,537,549, 2003
2992003
The value of drug repositioning in the current pharmaceutical market.
EL Tobinick
Drug news & perspectives 22 (2), 119-125, 2009
2782009
Right ventricular ejection fraction in patients with acute anterior and inferior myocardial infarction assessed by radionuclide angiography
KJS Tobinick E, Schelbert HR, Henning H, LeWinter M, Taylor A, Ashburn WL
Circulation 57 (6), 1078-84, 1978
2401978
Tumor necrosis factor antagonists for the treatment of neurological disorders
EL Tobinick, AJ Tobinick
US Patent 6,015,557, 2000
1862000
Cytokine antagonists for neurological and neuropsychiatric disorders
EL Tobinick
US Patent 6,982,089, 2006
1582006
Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept
E Tobinick, NM Kim, G Reyzin, H Rodriguez-Romanacce, V DePuy
CNS drugs 26, 1051-1070, 2012
1572012
TNT inhibitors for the treatment of neurological disorders
EL Tobinick
US Patent 6,177,077, 2001
1572001
Cytokine antagonists for the treatment of localized disorders
EL Tobinick
US Patent 6,537,549, 2003
1522003
The cerebrospinal venous system: anatomy, physiology, and clinical implications
E Tobinick, CP Vega
MedGenMed 8 (1), 53, 2006
1482006
Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease
EL Tobinick, H Gross
BMC neurology 8, 1-9, 2008
1442008
Tumour necrosis factor modulation for treatment of Alzheimer’s disease: rationale and current evidence
E Tobinick
CNS drugs 23, 713-725, 2009
1382009
Perispinal TNF-alpha inhibition for discogenic pain
EL Tobinick, S Britschgi-Davoodifar
Swiss medical weekly 133 (1112), 170-170, 2003
1372003
TNF inhibitors for the treatment of neurological, retinal and muscular disorders
EL Tobinick
US Patent 6,379,666, 2002
1282002
Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients
E Tobinick, S Davoodifar
Current medical research and opinion 20 (7), 1075-1085, 2004
1262004
TNF modulators for treating neurological disorders associated with viral infection
EL Tobinick
US Patent 6,419,934, 2002
1172002
Cytokine antagonists for the treatment of sensorineural hearing loss
EL Tobinick
US Patent 6,423,321, 2002
1082002
Perispinal etanercept for treatment of Alzheimer's disease
E Tobinick
Current Alzheimer Research 4 (5), 550-552, 2007
1022007
The system can't perform the operation now. Try again later.
Articles 1–20